A role for parathyroid hormone-related protein in the pathogenesis of inflammatory/autoimmune diseases

International Immunopharmacology

Volumn 1, Issue 6, 2001, Pages 1101-1121

  Funk, Janet L ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b Endocrinology   (United States)

Author keywords

Endotoxin; PTHrP; Rheumatoid arthritis; TNF

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; DEXAMETHASONE; ENDOTOXIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NEUTRALIZING ANTIBODY; PARATHYROID HORMONE RECEPTOR; PARATHYROID HORMONE RELATED PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ANIMAL MODEL; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; ENDOTOXEMIA; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY DISEASE; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM;

EID: 0035036346     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(01)00040-6     Document Type: Review

References (133)

1. Kollias G., Douni E., Kassiotis G., Kontoyiannis The function of TNF and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Ann. Rheum. Dis. 58(S1):1999;I32-I39.
2. Dinarello C.A. The proinflammatory cytokines IL-1 and TNF and the treatment of septic shock syndrome. J. Infect. Dis. 163:1991;1177-1184.
3. Gadient R.A., Patterson P.H. Leukemia inhibitory factor, Interleukin 6, and other cytokines using the GP130 transducing receptor: roles in inflammation and injury. Stem Cells. 17:1999;127-137.
4. Strewler G.J. Humoral manifestations of malignancy. Wilson J.D., Foster D.W., Kronenberg H.M., Larsen P.R. William's Textbook Endocrinology. 1998;693-1710 WB Saunders, Philadelphia.
5. Dunbar M.E., Wysolmerski J.J., Broadus A.E. PTHrP: from hypercalcemia of malignancy to developmental regulatory molecule. Am. J. Med. Sci. 312:1996;287-294.
6. Philbrick W.M., Wysolmerski J.J., Galbraith S., Holt E., Orloff J.J.et al. Defining the roles of PTHrP in normal physiology. Physiol. Rev. 76:1996;127-173.
7. Bringhurst F.R., Demay M.B., Kronenberg H.M. Hormones and disorders of mineral metabolism. Wilson J.D., Foster D.W., Kronenberg H.M., Larsen P.R. William's Textbook Endocrinology. 1998;1155-1210 WB Saunders, Philadelphia.
8. Usdin T.B., Gruber C., Bonner T.I. Identification and functional expression of a receptor selectively recognizing PTH, the PTH2 receptor. J. Biol. Chem. 270:1995;15455-15458.
9. Wysolmerski J.J., Stewart A.F. The physiology of PTHrP: an emerging role as a developmental factor. Annu. Rev. Physiol. 60:1998;431-460.
10. Strewler G.J. The physiology of PTHrP. New Eng. J. Med. 342:2000;177-185.
11. Karaplis Ac., Luz A., Glowacki J., Bronson R.T., Tybulewicz V.L.J.et al. Lethal skeletal dysplasia from targeted disruption of the PTHrP gene. Genes Dev. 8:1994;277-289.
12. Lanske B., Karaplis A.C., Lee K., Luz A., Vortkamp A.et al. PTH/PTHrP receptor in early deveopment and Indian hedgehog-regulated bone growth. Science. 273:1996;663-666.
13. Zhang P., Jobert A.S., Couvineau A., Silve C. A homozygous inactivating mutation in the PTH/PTHrP receptor causing Blomstrand chondrodysplasia. J. Clin. Endocrinol. Metab. 83:1998;3365-3368.
14. Dunbar M.E., Wysolmerski J.J. Parathyroid hormone-related protein: a developmental regulatory molecule necessary for mammary gland development. J. Mammary Gland Biol. Neoplasia. 4:1999;21-34.
15. Dunbar M.E., Dann P.R., Robinson G.W., Hennighausen L., Zhang J.P.et al. Parathyroid hormone-related protein signaling is necessary for sexual dimorphism during embryonic mammary development. Development. 126:1999;3485-3493.
16. Mundy G.R., Guise T.A. Hypercalcemia of malignancy. Am. J. Med. 103:1997;134-145.
17. Nagai Y., Yamato H., Akaogi K., Hirose K., Ueyama Y.et al. Role of IL-6 in uncoupling of bone in vivo in a human squamous carcinoma coproducing PTHrP and IL-6. J. Bone Miner. Res. 13:1998;664-672.
18. Sato K., Fujii Y., Kakiuchi T., Kasono K., Imamura H., Kondo Y.et al. Paraneoplastic syndrome of hypercalcemia and leukocytosis caused by squamous carcinoma cells (T3M-1) producing PTHrP, IL-1alpha, and G-CSF. Cancer Res. 49:1989;4740-4746.
19. Mori H., Aoki K., Katayama I., Nishioka K., Umeda T. Humoral hypercalcemia of malignancy with elevated plasma PTHrP, TNF alpha, and IL-6 in cutaneous squamous cell carcinoma. J. Dermatol. 136:1996;3412-3421.
20. Morony S., Capparelli C., Lee R., Shimamoto G., Boone T.et al. A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP and 1,25(OH)2D3. J. Bone Miner. Res. 14:1999;1478-1485.
21. Sato K., Fujii Y., Kasono K., Ozawa M. PTHrP and IL-1 synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in mice in vivo. Endocrinology. 124:1989;2172-2176.
22. Uy H., Mundy G.R., Boyce B.F., Story B.M., Dunstan C.R.et al. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo. Cancer Res. 57:1997;3194-3199.
23. de la Mata J., Uy H.L., Guise T.A., Story B., Boyce B.F.et al. IL-6 enhances hypercalcemia and bone resorption mediated by PTHrP in vivo. J. Clin. Invest. 95:1995;2846-2852.
24. Greenfield E.M., Shaw S.M., Gornik S.A., Banks M.A. Adenyl cyclase and IL-6 are downstream effectors of PTH resulting in stimulation of bone resorption. J. Clin. Invest. 96:1995;1238-1244.
25. Grey A., Mitnick M.A., Masiukiewicz U., Sun B.H., Rudikoff S.et al. A role for IL-6 in PTH-induced bone resorption in vivo. Endocrinology. 140:1999;4683-4690.
26. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood. 87:1996;2095-2147.
27. Carswell E.A., Old L.J., Kassel R.L., Green S., Fiore N., Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. U. S. A. 72:1975;3666-3670.
28. Bone R.C. The pathogenesis of sepsis. Ann. Intern. Med. 115:1991;457-469.
29. Parrillo J.E. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328:1993;1471-1477.
30. Fong Y., Tracy K.J., Moldawer L.L., Hesse D.G., Manogue K.B.et al. Antibodies to cachectin/TNF reduce IL-1beta and IL-6 appearance during lethal bacteremia. J. Exp. Med. 170:1989;1627-1633.
31. Feldmann M., Brennan F.M., Maini R.N. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14:1996;397-440.
32. Ulich T.R., Guo K., Yin S., del Castillo J., Yi E.S.et al. Endotoxin-induced cytokine gene expression in vivo: IV. Expression of interleukin-1 alpha/beta and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation. Am. J. Pathol. 141:1992;61-68.
33. Ulich T.R., Guo K., del Castillo J. Endotoxin-induced cytokine gene expression in vivo: I. Expression of tumor necrosis factor mRNA in visceral organs under physiologic conditions and during endotoxemia. Am. J. Pathol. 134:1989;11-14.
34. Ulich T.R., Guo K.Z., Remick D., del Castillo J., Yin S.M. Endotoxin-induced cytokine gene expression in vivo: III. IL-6 mRNA and serum protein expression and the in vivo hematologic effects of IL-6. J. Immunol. 146:1991;2316-2323.
35. Funk J.L., Moser A.H., Strewler G.J., Feingold K.R., Grunfeld C. PTHrP is induced during lethal endotoxemia and contributes to endotoxin-induced mortality in rodents. Mol. Med. 2:1996;204-210.
36. Funk J.L., Krul E.J.T., Moser A.H., Shigenaga J.K., Strewler G.J.et al. Endotoxin increases parathyroid hormone-related protein mRNA levels in mouse spleen: mediation by tumor necrosis factor. J. Clin. Invest. 92:1993;2546-2552.
37. Funk J.L., Shigenaga J.K., Moser A.H., Krul E.J.T., Strewler G.J.et al. Cytokine regulation of parathyroid hormone-related protein mRNA levels in mouse spleen: paradoxical effects of interferon-gamma and interleukin-4. Endocrinology. 135:1994;351-358.
38. Fischer E., Marano M.A., Van Zee K.J., Rock C.S., Hawes A.S.et al. Il-1 Receptor blockade improves survival and hemodynamic performance in E. coli septic shock, but fails to alter host response to sublethal endotoxemia. J. Clin. Invest. 89:1992;1551-1557.
39. Fong Y., Marano M.A., Moldawer L.L., Wei H., Calvano S.et al. The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J. Clin. Invest. 85:1990;1896-1904.
40. Giroir B.P., Johnson J.H., Brown T., Allen G.L., Beutler B. The tissue distribution of TNF biosynthesis during endotoxemia. J. Clin. Invest. 90:1992;693-698.
41. Funk J.L., Lausier J., Moser A.H., Shigenaga J.K., Huling S.et al. Endotoxin induces parathyroid hormone-related protein gene expression in splenic stromal cells - not in splenic lymphocytes. Endocrinology. 136:1995;3412-3421.
42. Motokura T., Fukumoto S., Takahashi S., Watanabe T., Matsumoto T., Igarashi T.et al. Expression of parathyroid hormone-related protein in a human T cell lymphotrophic virus type 1-infected T cell line. Biochem. Biophys. Res. Commun. 154:1988;1182-1188.
43. Adachi N., Yamaguchi K., Miyake Y., Honda S., Nagasaki K.et al. Parathyroid hormone-related protein is a possible autocrine growth inhibitor for lymphocytes. Biochem. Biophys. Res. Commun. 166:1990;1088-1094.
44. Wada S., Kitamura H., Matsuura Y., Katayama Y., Ohkawa H.et al. Parathyroid hormone-related protein as a cause of hypercalcemia in a B-cell type malignant lymphoma. Intern. Med. 31:1992;968-972.
45. Hunt J.S., Chen H.L., Hu X.L., Chen T.Y., Morrison D.C. TNF-alpha gene expression in the tissues of normal mice. Cytokine. 4:1992;340-346.
46. Hartwig H., Hartwig H.G. Structural characteristics of the mammalian spleen indicating storage and release of red blood cells. Aspects of evolutionary and environmental demands. Experientia. 41:1985;159-163.
47. Freudenberg N., Freudenberg M.A., Bandara K., Galanos C. Distribution and localization of endotoxin in the reticulo-endothelial system (RES) and in the main vessels of the rat during shock. Pathol., Res. Pract. 179:1985;517-527.
48. Bone R.C. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit. Care Med. 24:1996;163-172.
49. Kusher I. The acute phase response: from Hippocrates to cytokine biology. Eur. Cytokine Net. 2:1991;75-80.
50. Ramadori G., Christ B. Cytokines and the hepatic acute-phase response. Sem. Liver Dis. 19:1999;141-155.
51. Baumann H., Gauldie J. The acute phase response. Immunol. Today. 15:1994;74-80.
52. Malle E., Steinmetz A., Raynes J.G. Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis. 102:1993;131-146.
53. Steel D.M., Whitehead A.S. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol. Today. 15:1994;81-88.
54. Selinger M.J., McAdam K.P.W.J., Kaplan M.M., Sipe J.D., Vogel S.N., Rosenstreich D.L. Monokine-induced synthesis of serum amyloid A protein by hepatocytes. Nature. 285:1980;498-500.
55. Grunfeld C., Feingold K.R. Regulation of lipid metabolism by cytokines during host defense. Nutrition. 12:1996;S24-S26.
56. Feingold K.R., Funk J.L., Moser A.H., Shigenaga J.K., Rapp J.H., Grunfeld C. Role for circulating lipoproteins in protection from endotoxin toxicity. Infect. Immunol. 63:1995;2041-2046.
57. Leong J.C., Kane J.P., Oleszko O., Levy J.A. Antigen specific nonimmunoglobulin factor that neutralizes xenotrophic virus is associated with mouse serum lipoproteins. Proc. Natl. Acad. Sci. U. S. A. 74:1977;276-280.
58. Kushner I., Feldmann G. Control of the acute phase response: demonstration of C-reactive protein synthesis and secretion by hepatocytes during acute inflammation in the rabbit. J. Exp. Med. 148:1978;466-477.
59. Gauldie J., Lamontagne L., Horsewood P., Jenkins E. Immunohistochemical localization of alpha 1-antitrypsin in normal mouse liver and pancreas. Am. J. Pathol. 101:1980;723-735.
60. Funk J.L., Moser A.H., Grunfeld C., Feingold K.R. Parathyroid hormone-related protein is induced in the adult liver during endotoxemia and stimulates the hepatic acute phase response. Endocrinology. 138:1997;2665-2673.
61. Memon R.A., Grunfeld C., Moser A.H., Feingold K.R. Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice. Endocrinology. 132:1993;2246-2253.
62. Adi S., Pollock A.S., Shigenaga J.K., Moser A.H., Feingold K.R., Grunfeld C. Role for monokines in the metabolic effect of endotoxin. J. Clin. Invest. 89:1992;1603-1609.
63. Grunfeld C., Adi S., Soued M., Moser A., Fiers W., Feingold K.R. Search for mediators of the lipogenic effects of TNF: potential role for IL-6. Cancer Res. 50:1990;4233-4238.
64. Feingold K.R., Grunfeld C. TNF stimulates hepatic lipogenesis in the rat in vivo. J. Clin. Invest. 80:1987;184-190.
65. Feingold K.R., Soued M., Adi S., Staprans I., Neese R.et al. Effect of IL-1 on lipid metabolism in the rat. Arterioscler., Thromb. 11:1991;495-500.
66. Nonogaki K., Fuller G.M., Fuentes N.L., Moser A.H., Staprans I.et al. Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology. 136:1995;2143-2149.
67. Mitnick M., Grey A., Masiukiewicz U., Rios-Velez L., Jacobs A.et al. PTH stimulates hepatic production of bioactive IL-6. Bone. 23:1998;S197.
68. Usdin T.B., Bonner T.I., Harta G., Mezey E. Distribution of PTH-2 receptor mRNA in rat. Endocrinology. 137:1996;4285-4297.
69. Li H., Seitz P.K., Selvanyagam P., Rajaraman S., Cooper C.W. Effect of endogenously produced parathyroid hormone-related peptide on growth of a human hepatoma cell line (Hep G2). Endocrinology. 137:1996;2367-2374.
70. Beutler B., Milssark I.W., Cerami A.C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 229:1985;869-871.
71. Tracey K.J., Fong Y., Hesse D.G., Manogue K.R., Lee A.T.et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 330:1987;662-664.
72. Ohlsson K., Bjork P., Bergenfeldt M., Hageman R., Thompson R.C. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature. 348:1990;550-552.
73. Ferguson J.E., Seaner R.M., Bruns D.E., Bruns M.E. IL-1 and IL-4 increase PTHrP secretion by human umbilical vein endothelial cells. Am. J. Obstet. Gynecol. 173:1995;448-455.
74. Eto M., Akishita M., Ishikawa M., Kozaki K., Yoshizumi M.et al. Cytokine-induced expression of PTHrP in cultured human vascular endothelial cells. Biochem Biophys Res. Commun. 249:1998;339-343.
75. Quian J., Lorenz J.N., Maeda S., Sutliff R.O., Weber C.et al. Reduced blood pressure and increased senstivity of the vasculature to PTHrP in transgenic mice overexpressing the PTH/PTHrP receptor in vascular smooth muscle. Endocrinology. 140:1999;1826-1833.
76. Harris E.D. Rheumatoid arthritis: pathophysiology and implications for therapy. New Engl. J. Med. 322:1990;1277-1288.
77. Maini R.N., Taylor P.C. Anti-cytokine therapy for rheumatoid arthritis. Annu. Rev. Med. 51:2000;207-229.
78. Funk J.L., Cordaro L.A., Wei H., Benjamin J.B., Yocum D.E. Synovium as a source of increased PTHrP expression in rheumatoid arthritis. J. Clin. Invest. 101:1998;1362-1371.
79. Pandian M.R., Morgan C.H., Carlton E., Segre G.V. Modified immunoradiometric assay of parathyroid hormone-related protein: clinical applications in the differential diagnosis of hypercalcemia. Clin. Chem. 38:1992;282-288.
80. Okano K., Tsukazaki T., Ohtsuru A., Namba H., Osaki M.et al. Parathyroid hormone-related peptide in synovial fluid and disease activity of rheumatoid arthritis. Br. J. Rheumatol. 35:1996;1056-1062.
81. Kohno H., Shigeno C., Kasai R., Akiyama H., Iida H.et al. Synovial fluids from patients with osteoarthritis and rheumatoid arthritis contain high levels of parathyroid hormone-related peptide. J. Bone Miner. Res. 12:1997;847-854.
82. Horiuchi T., Yoshida T., Koshihara Y., Sakamoto H., Kanai H.et al. The increase of parathyroid hormone-related peptide and cytokine levels in synovial fluid of elderly rheumatoid arthritis and osteoarthritis. Endocr. J. 46(5):1999;643-649.
83. Romas E., Kartsogiannis V., Ho P.W.M., Mosely J.M., Martin T.J. PTHrP is expressed in chronic inflammatory arthritis. J. Bone Miner. Res. 12:1997;S513.
84. Yocum D.E., Esparza L., Dubry S., Benjamin J.B., Volz R., Scuderi P. Characteristics of TNF production in RA. Cellular Immunol. 122:1989;131-145.
85. Firestein G.S., Alvaro-Garcia J.M., Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J. Imunol. 144:1990;3347-3353.
86. Chu C.Q., Field M., Feldmann M., Maini R.N. Localization of TNF-α in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum. 34:1991;1125-1132.
87. Deleuran B.W., Chu C.Q., Field M., Brennan R.M., Katsikis P.et al. Localization of IL-1α, I. Type, IL-1 receptor and IL-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. Br. J. Rheumatol. 31:1992;801-809.
88. Okano K., Tsukazaki T., Ohtsuru A., Osaki M., Yonekura A., Iwasaki K.et al. Expression of parathyroid hormone-related peptide in human osteoarthritis. J. Orthop. Res. 15:1997;175-180.
89. Terkeltaub R., Lotz M., Johnson K., Deng D., Hashimoto S., Goldring M.B.et al. Parathyroid hormone-related proteins is abundant in osteoarthritic cartilage, and the parathyroid hormone-related protein 1-173 isoform is selectively induced by transforming growth factor beta in articular chondrocytes and suppresses generation of extracellular inorganic pyrophosphate. Arthritis Rheum. 41:1998;2152-2164.
90. Yoshida T., Horiuchi T., Sakamoto H., Inoue H., Takayanagi H.et al. Production of parathyroid hormone-related peptide by synovial fibroblasts in human osteoarthritis. FEBS Lett. 433(3):1998;331-334.
91. Baker D.G., Dayer J.M., Roelke M., Schumacher H.R., Krane S.M. Rheumatoid synovial cell morphologic changes induced by a mononuclear cell factor in culture. Arthritis Rheum. 26:1983;8-14.
92. Tetlow L.C., Lees M., Ogata Y., Nagase H., Wooley D.E. Differential expression of gelatinase B (MMP-9) and stromelysin-1 (MMP-3) by rheumatoid synovial cells in vitro and in vivo. Rheum. Int. 13:1993;53-59.
93. Werb Z., Hembry R.M., Murphy G., Aggeler J. Commitment to expression of the metalloendopeptidases, collagenase and stromelysin: relationship of inducing events to changes in cytoskeletal architecture. J. Cell Biol. 102:1986;697-702.
94. Amano Y., Lee S.W., Allison A.C. Inhibition by glucocorticoids of the formation of IL-1alpha, IL-1beta, and IL-6: mediation by decreased mRNA stability. Mol. Pharmacol. 43:1993;176-182.
95. Dayer J.M., Krane S.M., Graham R., Russell G., Robeinson D.R. Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells. Proc. Natl. Acad. Sci. 73:1976;945-949.
96. 2, and collagenase release. Ann. Rheum. Dis. 49:1990;512-516.
97. Alvaro-Gracia J.M., Zvaifler N.J., Firestein G.S. Cytokines in chronic inflammatory arthritis: V. Mutual antagonism between IFNγ and TNFα on HLA-DR expression, proliferation, collagenase production, and GM-CSF production by rheumatoid arthritis synoviocytes. J. Clin. Invest. 86:1990;1790-1798.
98. Cush J., Kavanaugh A.F. Biologic interventions in RA. Rheum. Dis. Clin. Nor. Am. 21:1995;797-816.
99. Kirwan J.R. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N. Engl. J. Med. 333:1995;142-146.
100. Ikeda K., Lu C., Weir E.C., Mangin M., Broadus A.E. Transcriptional regulation of the parathyroid hormone-related peptide gene by glucocorticoids and vitamin D in a human C-cell line. J. Biol. Chem. 264:1989;15743-15746.
101. Hongo T., Kupfer J., Enomoto H., Sharifi B., Giannella-Neto D.et al. Abundant expression of parathyroid hormone-related protein in primary rat aortic smooth muscle cells accompanies serum-induced proliferation. J. Clin. Invest. 88:1991;1841-1847.
102. Paspaliaris V., Petersen D.N., Thiede M.A. Steroid regulation of parathyroid hormone-related protein expression and action in the rat uterus. J. Steroid Biochem. Mol. Biol. 53:1995;259-265.
103. Suda T., Takahasi N., Udagawa N., Jimi E., Gillespie M.T., Martin T.J. Modulation of osteoclast diffferentiation and function by the new members of the TNF receptor and ligand families. Endocr. Rev. 20:1999;345-357.
104. Kudo S., Mizuta H., Otsuka Y., Takagi K., Hiraki Y. Inhibition of chondrogenesis by parathyroid hormone in vivo during repair of full-thickness defects of articular cartilage. J. Bone Miner. Res. 15:2000;253-260.
105. Kawashima-Ohya Y., Satakeda H., Kuruta Y., Kawamoto T., Yan W.et al. Effects of parathyroid hormone (PTH) and PTH-related peptide on expressions of matrix metalloproteinase-2, -3, and -9 in growth plate chondrocyte cultures. Endocrinology. 139:1998;2120-2127.
106. O'Keefe R.J., Loveys L.S., Hicks D.G., Reynolds P.R., Crabb I.D.et al. Differential regulation of type-II and type-X collagen synthesis by parathyroid hormone-related protein in chick growth-plate chondrocytes. J. Orthop. Res. 15:1997;162-174.
107. Tsukazaki T., Ohtsuru A., Namba H., Oda J., Motomura K.et al. Parathyroid hormone-related protein (PTHrP) action in rat articular chondrocytes: comparison of PTH(1-34), PTHrP(1-34), PTHrP(1-141), PTHrP(100-114) and antisense oligonucleotides against PTHrP. J. Endocrinol. 150(3):1996;359-368.
108. Alonzi T., Fattori E., Lazzaro D., Costa P., Probert L.et al. IL-6 is required for the development of collagen-induced arthritis. J. Exp. Med. 187:1998;461-468.
109. Boe A., Baiocchi M., Carbonatto M., Papoian R., Serlupi-Crescenzi O. Interleukin 6 knock-out mice are resistant to antigen-induced experimental arthritis. Cytokine. 11:1999;1057-1064.
110. Funk J.L., Jones G.V., Botham C.A., Morgan G., Wooding P., Kendall M.D. Expression of PTHrP and the PTH/PTHrP receptor in rat thymic epithelial cells. J. Anat. 194:1999;255-264.
111. van den Berg W.B. Joint inflammation and cartilage destruction may occur uncoupled. Springer Semin. Immunophathol. 20:1998;149-164.
112. Wronski T.J., Yen C.F., Qi H., Dann L.M. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats. Endocrinology. 132:1993;823-831.
113. Vickery B.H., Avnur Z., Cheng Y., Chiou S.S., Leaffer D.et al. RS-66271, a C-terminally substituted analog of human parathyroid hormone-related protein (1-34), increases trabecular and cortical bone in ovariectomized, osteopenic rats. J. Bone Miner. Res. 11:1996;1943-1951.
114. Reeve J., Bradbeer J.N., Arlot M., Davies U.M., Green J.R.et al. hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses. Osteoporosis Int. 1:1991;162-170.
115. Finkelstein J.S., Klibanski A., Schaefer E.H., Hornstein M.D., Schiff I., Neer R.M. Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N. Engl. J. Med. 331:1994;1618-1623.
116. Lindsay R., Nieves J., Formica C., Henneman E., Woelfert L.et al. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet. 350:1997;550-555.
117. Lane N.E., Sanchez S., Modin G.W., Genant H.K., Ini E., Arnaud C.D. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. J. Clin. Invest. 102:1998;1627-1633.
118. Plotkin H., Gundberg C., Mitnick M., Stewart A.F. Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1-36) in humans: potential as an anabolic therapy for osteoporosis. J. Clin. Endocrinol. Met. 83:1998;2786-2791.
119. Stewart A.F. PTHrP(1-36) as a skeletal anabolic agent for the treatment of osteoporosis. Bone. 19:1996;303-306.
120. Morley P., Whitfield J.F., Willick G.E. Design and applications of parathyroid hormone analogues. Curr. Med. Chem. 6:1999;1095-1106.
121. Mierke D.F., Pellegrini M. Parathyroid hormone and parathyroid hormone-related protein: model systems for the development of an osteoporosis therapy. Curr. Pharm. Des. 5:1999;21-36.
122. Vasavada R.C., Cavaliere C., D'Ercole A.J., Dann P., Burtis W.J.et al. Overexpression of parathyroid hormone-related protein in the pancreatic islets of transgenic mice causes islet hyperplasia, hyperinsulinemia, and hypoglycemia. J. Biol. Chem. 271:1996;1200-1208.
123. Almawi W.Y., Tamim H., Azar S.T. Clinical review 103: T helper type 1 and 2 cytokines mediate the onset and progression of type I (insulin-dependent) diabetes. J. Clin. Endocrinol. Metab. 84:1999;1497-1502.
124. Satoh J., Seino H., Abo T., Tanaka S., Shintani S.et al. Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice. J. Clin. Invest. 84:1989;1345-1348.
125. Deftos L.J., Burton D.W., Baird S.M., Terkeltaub R.A. Hypercalcemia and systemic lupus erythematosus. Arthritis Rheum. 39:1996;2066-2069.
126. Gillian S., Deana G.S., Tyrrell-Price J., Crawley E., Isenberg D.A. Cytokines and systemic lupus erythematosus. Ann. Rheum. Dis. 59:2000;243-251.
127. Thiede M.A., Harm S.C., Hasson D.M., Gardner R.M. In vivo regulation of parathyroid hormone-related peptide messenger ribonucleic acid in the rat uterus by 17 beta-estradiol. Endocrinology. 128:1991;2317-2323.
128. Casey M.L., Mibe M., MacDonald P.C. Regulation of parathyroid hormone-related protein gene expression in human endometrial stromal cells in culture. J. Clin. Endocrinol. Metab. 77:1993;188-194.
129. Holt E.H., Lu C., Dreyer B.E., Dannies P.S., Broadus A.E. Regulation of parathyroid hormone-related peptide gene expression by estrogen in GH4C1 rat pituitary cells has the pattern of a primary response gene. J. Neurochem. 62:1994;1239-1246.
130. Funk J.L., Wei H. Regulation of parathyroid hormone-related protein expression in MCF-7 breast carcinoma cells by estrogen and antiestrogens. Biochem. Biophys. Res. Commun. 251:1998;849-854.
131. Cros M., Silve C., Graulet A.M., Morieux C., Urena P.et al. Estrogen stimulates PTHrP but not PTH/PTHrP receptor gene expression in the kidney of ovariectomized rat. J. Cell. Biochem. 70:1998;84-93.
132. Dobnig H., Kainer F., Stepan V., Winter R., Lipp R.et al. Elevated parathyroid hormone-related peptide levels after human gestation: relationship to changes in bone and mineral metabolism. J. Clin. Endocrinol. Metab. 80:1995;3699-3707.
133. Gallacher S.J., Fraser W.D., Owens O.J., Dryburgh F.J., Logue F.C.et al. Changes in calciotrophic hormones and biochemical markers of bone turnover in normal human pregnancy. Eur. J. Endocrinol. 131:1994;369-374.